Abstract
Background and ObjectivesAtezolizumab has demonstrated safety and efficacy in patients with metastatic non-small cell lung cancer (NSCLC) in the IMpow......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
